BARCLAYS PLC - JANUX THERAPEUTICS INC ownership

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of JANUX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$181
+178.5%
17,922
+227.1%
0.00%
Q2 2023$65
-39.8%
5,479
-38.5%
0.00%
Q1 2023$108
+77.0%
8,904
+93.2%
0.00%
Q4 2022$61
-99.4%
4,608
+533.0%
0.00%
Q3 2022$10,000
-9.1%
728
-15.3%
0.00%
Q2 2022$11,000
-73.8%
860
-70.8%
0.00%
Q1 2022$42,0002,9480.00%
Other shareholders
JANUX THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 8,670,644$117,401,0002.50%
5AM Venture Management, LLC 446,266$6,042,0001.16%
Samsara BioCapital, LLC 360,414$4,880,0001.14%
BVF INC/IL 1,470,334$19,908,0000.82%
Orbimed Advisors 2,836,386$38,405,0000.71%
EcoR1 Capital, LLC 1,421,319$19,245,0000.57%
Woodline Partners LP 400,181$5,418,0000.08%
Parkwood LLC 33,352$452,0000.07%
JANUS HENDERSON GROUP PLC 3,920,088$26,572,5460.02%
Cerity Partners LLC 105,933$1,434,0000.02%
View complete list of JANUX THERAPEUTICS INC shareholders